Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

Researchers describe the symptom profiles of respiratory viral infections.

Risk adjusted net present value: What is the current valuation of Johnson & Johnson’s PN-235?

PN-235 is a synthetic peptide commercialized by Johnson & Johnson, with a leading Phase III program in Plaque Psoriasis (Psoriasis Vulgaris).

March 14, 2024

Meta Title: Allscripts Healthcare Solutions Inc Patent Filing for Medical Software Optimization

Share this article According to GlobalData’s company profile on Allscripts Healthcare Solutions, was a key innovation area identified from patents. Allscripts Healthcare Solutions’s grant share

April 15, 2024

Using genetics to gain better insights into human behavior

Humans contain multitudes. Each person on the planet contains enough DNA to stretch to Pluto – several times.

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.